当前位置： SCI文献检索 > CELL TRANSPLANTATION期刊下所有文献 > Insulin-secreting pituitary GH3 cells: a potential beta-cell surrogate for diabetes cell therapy.

Insulin-secreting pituitary GH3 cells: a potential beta-cell surrogate for diabetes cell therapy.

Abstract：

:In a companion article, we describe the engineering and characterization of pituitary GH3 cell clones stably transfected with a furin-cleavable human insulin cDNA (InsGH3 cells). This article describes the performance of InsGH3 (clones 1 and 7) cell grafts into streptozotocin (STZ)-induced diabetic nude mice. Subcutaneous implantation of 2 x 10(6) InsGH3 cells resulted in the progressive reversal of hyperglycemia and diabetic symptoms, even though the progressive growth of the transplanted cells (clone 7) eventually led to glycemic levels below the normal mouse range. Proinsulin transgene expression was maintained in harvested InsGH3 grafts that, conversely, lose the expression of the prolactin (PRL) gene. Elevated concentrations of circulating mature human insulin were detected in graft recipients, demonstrating that proinsulin processing by InsGH3 cells did occur in vivo. Histologic analysis showed that transplanted InsGH3 grew in forms of encapsulated tumors composed of cells with small cytoplasms weakly stained for the presence of insulin. Conversely, intense insulin immunoreactivity was detected in graft-draining venules. Compared to pancreatic betaTC3 cells, InsGH3 cells showed in vitro a higher rate of replication, an elevate resistance to apoptosis induced by serum deprivation and proinflammatory cytokines, and significantly higher antiapoptotic Bcl-2 protein levels. Moreover, InsGH3 cells were resistant to the streptozotocin toxicity that, in contrast, reduced betaTC3 cell viability to 50-60% of controls. In conclusion, proinsulin gene expression and mature insulin secretion persisted in transplanted InsGH3 cells that reversed hyperglycemia in vivo. InsGH3 cells might represent a potential beta-cell surrogate because they are more resistant than pancreatic beta cells to different apoptotic insults and might therefore be particularly suitable for encapsulation.

journal_name

Cell Transplant

journal_title

Cell transplantation

authors

Davalli AM,Galbiati F,Bertuzzi F,Polastri L,Pontiroli AE,Perego L,Freschi M,Pozza G,Folli F,Meoni C

doi

10.1177/096368970000900610

subject

Has Abstract

pub_date

2000-11-01 00:00:00

pages

841-51

issue

eissn

0963-6897

issn

1555-3892

journal_volume

pub_type

杂志文章

在线工具

Insulin-secreting pituitary GH3 cells: a potential beta-cell surrogate for diabetes cell therapy.